David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 23.09% |
| 2 | Technology | 17.04% |
| 3 | Healthcare | 13.44% |
| 4 | Consumer Discretionary | 13.38% |
| 5 | Financials | 7.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
CALL
ConocoPhillips
COP
$155B
| $1.8M | ﹤0.01% |
27,000
-105,100
| -80% | -$7.07M |
|
|
PE
2177
CALL
DELISTED
PARSLEY ENERGY INC
PE
| $1.8M | ﹤0.01% |
93,100
+34,800
| +60% | +$639K |
|
|
NPTN
2178
DELISTED
NEOPHOTONICS CORP
NPTN
| $1.79M | ﹤0.01% |
284,451
+258,242
| +985% | +$1.81M |
|
2179
Cushman & Wakefield Ltd
CWK
$3.36B
| $1.79M | ﹤0.01% |
100,325
+3,598
| +4% | +$62K |
|
2180
Innospec
IOSP
$2.35B
| $1.78M | ﹤0.01% |
21,418
-8,451
| -28% | -$630K |
|
2181
PUT
Elevance Health
ELV
$86.9B
| $1.78M | ﹤0.01% |
6,200
-8,800
| -59% | -$2.55M |
|
|
CUTR
2182
DELISTED
Cutera, Inc.
CUTR
| $1.77M | ﹤0.01% |
100,484
+56,233
| +127% | +$882K |
|
|
CTB
2183
PUT
DELISTED
Cooper Tire & Rubber Co.
CTB
| $1.77M | ﹤0.01% |
59,400
| – | – |
|
|
UBNK
2184
DELISTED
United Financial Bancorp, Inc.
UBNK
| $1.77M | ﹤0.01% |
123,384
+25,205
| +26% | +$381K |
|
2185
PUT
Pricesmart
PSMT
$5.3B
| $1.77M | ﹤0.01% |
+30,000
| New | +$1.87M |
|
2186
CALL
Rio Tinto
RIO
$170B
| $1.77M | ﹤0.01% |
+30,000
| New | +$1.65M |
|
2187
American States Water
AWR
$3.53B
| $1.76M | ﹤0.01% |
24,700
-16,804
| -40% | -$1.15M |
|
2188
PUT
Adobe
ADBE
$115B
| $1.76M | ﹤0.01% |
6,600
-900
| -12% | -$227K |
|
|
MDSO
2189
DELISTED
Medidata Solutions, Inc.
MDSO
| $1.76M | ﹤0.01% |
+24,010
| New | +$1.73M |
|
2190
Bankunited
BKU
$3.31B
| $1.76M | ﹤0.01% |
52,612
-95,519
| -64% | -$3.29M |
|
2191
CALL
Southern Company
SO
$102B
| $1.76M | ﹤0.01% |
+34,000
| New | +$1.67M |
|
2192
PUT
McKesson
MCK
$104B
| $1.76M | ﹤0.01% |
15,000
-10,200
| -40% | -$1.26M |
|
|
CCXI
2193
DELISTED
ChemoCentryx, Inc.
CCXI
| $1.76M | ﹤0.01% |
126,359
-88,540
| -41% | -$1.01M |
|
2194
PUT
Rockwell Automation
ROK
$47.9B
| $1.75M | ﹤0.01% |
10,000
-6,200
| -38% | -$1.05M |
|
|
AXON
2195
CALL
Axon Enterprise
AXON
$49.5B
| $1.75M | ﹤0.01% |
32,200
-30,200
| -48% | -$1.55M |
|
2196
PUT
Koppers
KOP
$875M
| $1.75M | ﹤0.01% |
67,400
-44,500
| -40% | -$1.05M |
|
2197
CALL
Ciena
CIEN
$56.4B
| $1.75M | ﹤0.01% |
+46,800
| New | +$1.82M |
|
|
COUP
2198
PUT
DELISTED
Coupa Software Incorporated
COUP
| $1.75M | ﹤0.01% |
+19,200
| New | +$1.65M |
|
2199
Monro
MNRO
$382M
| $1.75M | ﹤0.01% |
20,186
+5,035
| +33% | +$381K |
|
|
AT
2200
DELISTED
Atlantic Power Corporation
AT
| $1.74M | ﹤0.01% |
692,345
+129,516
| +23% | +$330K |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $2.66B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.